AVA-2206
N/A
Report date: 2025/06/11 10:49:08
NME
Base Information
Drug NameAVA-2206
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAveroa SAS
China Registration ClassN/A
Develop Information
Active CompaniesInstitut Investigació Biomèdica BellvitgeConsorcio Centro de Investigación Biomédica en Red (CIBER)Universitat De Barcelona +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A